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Abstract: The main goal of this investigation was to develop and test a new method of treatment 
for human hepatocellular carcinoma (HCC). We present a method of carbon nanotube-enhanced 
laser thermal ablation of HepG2 cells (human hepatocellular liver carcinoma cell line) based on 
a simple multiwalled carbon nanotube (MWCNT) carrier system, such as human serum albumin 
(HSA), and demonstrate its selective therapeutic efficacy compared with normal hepatocyte cells. 
Both HepG2 cells and hepatocytes were treated with HSA–MWCNTs at various concentrations 
and at various incubation times and further irradiated using a 2 W, 808 nm laser beam. Transmis-
sion electron, phase contrast, and confocal microscopy combined with immunochemical staining 
were used to demonstrate the selective internalization of HSA–MWCNTs via Gp60 receptors 
and the caveolin-mediated endocytosis inside HepG2 cells. The postirradiation apoptotic rate 
of HepG2 cells treated with HSA–MWCNTs ranged from 88.24% (for 50 mg/L) at 60 sec to 
92.34% (for 50 mg/L) at 30 min. Significantly lower necrotic rates were obtained when human 
hepatocytes were treated with HSA–MWCNTs in a similar manner. Our results clearly show 
that HSA–MWCNTs selectively attach on the albondin (aka Gp60) receptor located on the 
HepG2 membrane, followed by an uptake through a caveolin-dependent endocytosis process. 
These unique results may represent a major step in liver cancer treatment using nanolocalized 
thermal ablation by laser heating.
Keywords: carbon nanotubes, albumin, HepG2 cells, noncovalent functionalization, laser 
irradiation, Gp60 receptor
Introduction
Hepatocellular carcinoma (HCC) represents a leading cause of cancer deaths 
worldwide.1–3 Despite recent discoveries in screening and early detection, HCC exhib-
its a rapid clinical course with an average survival of 6 months and an overall 5-year 
survival rate of 5%.4 As chemotherapy and radiotherapy show modest results5 and 
surgery is possible in 10%–30% of patients,6,7 new therapeutic methods offer hope 
for a better outcome.
Most data suggest that nanotechnologies could play a major role in the development 
of new anticancer therapies. A thermal approach using nanoparticles, nanoemulsion, pH-
responsive nanoparticles, nanoparticles combined with radiation, and nanovectors for 
drug delivery are the most explored nanoparticle-based cancer treatment methods.8
The ability of carbon nanotubes (CNTs) to convert near-infrared (NIR) laser 
radiation into heat, due to the photon–phonon and electron interactions,9 provides the International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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opportunity to create a new generation of immunoconjugates 
for cancer phototherapy, with good performance and effi-
cacy in selective cancer thermal ablation, as well as in the 
application of nanotechnology in molecular diagnostics 
(nanodiagnostics).8,10
Nanotechnology has already shown promising results 
in HCC research and treatment. Microwave11 ablation and 
radiofrequency12 ablation were proposed for the treatment 
of HCC. Intratumorally administered CNTs combined with 
laser irradiation proved to be efficient in the treatment of HCC 
on animal models.13 However, a major challenge in treating 
HCC is represented by therapies strictly directed toward 
the tumor cells inside the liver parenchyma. Generally, the 
use of targeting molecules such as antibodies, folates, and 
growth factors has been specifically proposed for carrying 
nanomaterials to the cancer cells and tumors.14–16 However, 
100% selective internalization of nanobioconjugates in the 
cancer cells remains problematic.17 This can be explained by 
the presence of the receptors used for the specific binding of 
the targeting molecules on the membranes of the noncancer-
ous cells, although in smaller concentrations compared with 
the cancer cells.18
The use of CNTs as bioactive molecules is still at an early 
research stage, but their unique physical and chemical proper-
ties hold great hope for cancer treatment.8,14,16–18 Nevertheless, 
there are many toxicity concerns to be addressed. It has 
been stated that a proficient method needed to minimize 
toxic effects and also to increase the level of therapeutic 
response for CNTs is represented by their conjugation to 
a carrier molecule.19–23 The use of these biological carriers 
for the development of specific and sensitive site-targeted 
bionanosystems also allows the selective internalization of 
CNTs into cancer cells.
Research data have shown that highly proliferative tumors 
have the capacity to create albumin deposits.24 The reports 
have demonstrated the liver cancer cells’ overexpression of 
specific human serum albumin (HSA) receptors and their 
ability to internalize large amounts of albumin through the 
mechanism of caveolae-mediated endocytosis.25 The result-
ing amino acids are further used for the synthesis of various 
substrates needed for tumor growth.26,27 Considering all these 
data together, we propose a method for the functionalization 
of multiwalled carbon nanotubes (MWCNTs) with HSA for 
the selective targeting and laser-mediated necrosis of liver 
cancer cells. To our knowledge, this is the first demonstra-
tion of selective targeting via Gp60 receptors located on the 
membrane of malignant liver cancer cells using a conjugate 
of HSA and CNTs.
Material and methods
Antibodies and reagents
For the experiments involving the noncovalent functionaliza-
tion of CNTs, MWCNTs (.90% carbon basis, OD × ID × L 
10–15 nm × 2–6 nm × 0.1–10 µm, product number 677248), 
HSA, and Sephacryl 100-HR were purchased from Sigma-Al-
drich (Steinheim, Germany), and all the other chemicals were 
purchased from Merck (Darmstadt, Germany). HepG2 cells 
and immortalized hepatocyte epithelial cells (CRL-4020) were 
purchased from ATCC (Rockville, MD, USA), and all the 
other reagents needed for cell culture were purchased from 
Sigma-Aldrich. For the experiments involving cell apoptosis, 
Cell Death Detection ELISAPLUS was purchased from Roche 
Applied Science (Mannheim, Germany). For immunostaining 
procedures, Draq5, 4′-6-diamidino-2-phenylindole (DAPI), 
and anti-caveolin-1−Cy3 antibody (Ab) produced in rabbit 
were purchased from Sigma-Aldrich. Polyclonal Gp60 Ab 
was prepared as previously described,28 and for use as a 
fluorescent probe a cy3 derivative of anti-Gp60 was prepared 
according to the existing protocol.29
Noncovalent functionalization  
of cNTs with hsA
A total of 60 mg MWCNTs were dispersed in a 3:1 (v/v) 
  mixture of concentrated sulfuric and nitric acid and sonicated 
for 3 × 10 s with a tip sonicator. Subsequently, the mixture was 
refluxed at 120°C for 30 min. The oxidized MWCNTs treated in 
water solution were then centrifuged at 8000 rpm to remove any 
large unreacted CNTs from the solution and metallic impurities. 
Finally, the oxidized MWCNTs were vacuum filtered through 
a 0.2-µm polycarbonate filter (Whatman) until the elution was 
clear and at neutral pH. The filter cake was dried overnight at 
room temperature. After filtration, the solution concentration 
was re-estimated using UV–Vis–NIR spectroscopy (JASCO 
V530, Gross-Umstadt, Germany). A total of 1 mg of fluorescein 
isothiocyanate (FITC) (10 mg/mL in dimethyl sulfoxide) was 
mixed with 50 mg HSA in sodium buffer (20 mM, pH 8.5), 
followed by incubation for 2 h in darkness, at room temperature, 
with continuous stirring. The HSA–FITC conjugate was puri-
fied by gel chromatography using a Sephacryl 100-HR column 
eluted with 10 mM phosphate buffered saline (PBS).30
Oxidized MWCNTs and HSA–FITC were mixed with 
deionized water at a concentration of 0.25 and 1.25 mg/mL, 
respectively. The mixture was sonicated for 1 h with a 
tip sonicator in an ice bath and was then centrifuged for 
5 min at 12,000 rpm. The solid was settled at the bottom 
of the centrifuge tube and consisted of unbound nanotubes, 
  impurities, metals, and bundles of oxidized nanotubes. International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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The resulting supernatant was collected and subjected to 
a second   centrifugation round. The supernatant collected 
contained the desired MWCNT–HSA conjugate.
For further purification, the supernatant was subjected 
to a gel chromatography purification process. Sephacryl 
100-HR that was presoaked and deaerated using a vacuum 
pump was packed up to 15 cm in a 2.5 cm diameter × 24 cm 
long glass column. The oxidized MWCNT–HSA supernatant 
recovered after centrifugation was layered on the top of the 
gel and eluted using water flowing under gravity. Volume 
fractions were collected for periods of 1 min duration and 
analyzed for the presence of MWCNTs and HSA by measur-
ing the absorbance at 500 and 280 nm, respectively, using 
the spectrophotometer (JASCO V530). Fractions showing 
protein content were pooled for further use.
Preparation of MWcNTs
The nonconjugated highly purified MWCNT control solution 
was prepared as previously described.31 The solution was 
diluted in minimum essential medium at a 1:10 (v/v) ratio.
characterization of MWcNTs 
bioconjugates
The morphology of MWCNTs functionalized with HSA was 
examined using a WITEC alpha 300 Atomic Force Micro-
scope (Ulm, Germany), operating under ambient conditions. 
The images were collected in tapping mode using a silicon 
nitride cantilever.
The optical properties of oxidized MWCNTs function-
alized with HSA–FITC were monitored using a UV–Vis 
spectrophotometer (JASCO V570).
Fourier transform infrared (FTIR) measurements 
were performed with a JASCO 6100 spectrometer in the 
4000–500 cm−1 spectral region, with a resolution of 4 cm−1 
using the KBr pellet technique.
cell culture
HepG2 and CRL-4020 cells, purchased from the American 
Type Culture Collection (ATCC) (Manassas, VA, USA), 
were grown in 25 cm3 Corning plastic plates in minimum 
essential medium, supplemented with 10% fetal bovine 
serum and 1% penicillin–streptomycin. The cells were main-
tained in a humidified 5% CO2 incubator at 37°C. The cells 
were kept in the logarithmic growth phase by routine passage 
every 3–4 days. When reaching confluence, the cells were 
split after rinsing with PBS and detached with trypsin.
For the experiments, the cells were cultivated to conflu-
ence on 60 mm plates. The MWCNTs functionalized with 
HSA were further administered to the cell cultures by adding 
to the culture medium and incubating for various periods of 
time (1 min; 30 min; 1 h; 5 h; 24 h) at increased concentra-
tions: 1, 5, 20, 50 mg/L. For each concentration, all the 
experiments were performed in triplicate.
cell characterization
For the microscopy analysis, the cells were trypsinated and 
transferred to 35 mm plates, at a density of 25 × 104 cells/dish. 
After administration and irradiation, the cells were thoroughly 
washed with 1× PBS three times, fixed with 10% formaldehyde 
solution for 10 min, washed three times with PBS, and stained 
with methyl green dye for 10 min. Cells in culture were exam-
ined using an Olympus CKX 31 (Munich, Germany) inverted 
microscope with phase contrast.
cell viability
The extent of apoptosis was evaluated using a Cell Death 
Detection ELISAPLUS assay kit from Roche Applied   Science. 
The assay is a quantitative sandwich enzyme-linked immuno-
sorbent assay (ELISA) that uses the fact that, due to cellular 
death, nucleosomes are released from the nucleus into the 
cytosol. These nucleosomes can be detected by antihistone 
biotin-labeled Abs. The nucleosome–Abs complex will bind 
to streptavidin-coated well plate and give a signal at 405 nm 
on the addition of substrate. After irradiating the cells that were 
previously treated with various doses of HSA–MWCNTs, the 
culture media were removed and briefly centrifuged in order to 
collect the floating cells. The culture dish was rinsed with PBS, 
and then 0.25% trypsin was added to detach the cells. Once 
detached, the cell suspension was combined with the cells col-
lected from the media. The resulting mixture of the cells was 
briefly spun to collect the cells. The supernatant was discarded, 
and the pelleted cells were resuspended in ice-cold PBS. The 
cell suspension was subjected to the final centrifugation, and 
the pellet was resuspended in the Roche lysis buffer. After 
30 min incubation at room temperature, the reaction mixture 
was centrifuged at 200 g (4°C) for 10 min. The pellet, which 
contains the nucleus, was removed, and the supernatant, which 
represents the cytoplasmic fraction, was aliquoted into new 
tubes and kept frozen at −80°C until use.
This supernatant solution would contain the fragmented 
nucleosomes if the cells underwent apoptosis. After measur-
ing the protein concentration of the resulting supernatant using 
bicinchoninic acid (BCA) assay, 20 g of total protein in 20 µL 
were added to the streptavidin-coated 96-well plate. Twenty 
microliters of each incubation buffer and DNA–  histone com-
plex was used as a background control and   positive control, International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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respectively. Then, 80 µL of immunoreagent was added to 
each well and incubated for 2 h at room temperature, with 
gentle and continuous stirring. After the incubation, the 
solution in the wells was thoroughly removed using gentle 
suction and rinsed three times in incubation buffer. Finally, 
100 µL of 2,2′-azino-bis-(3-ethylbenzthiazoline-6-sulfonic 
acid) (ABTS) substrate solution was added to each well and 
incubated until the desired strength of color was achieved, 
which took about 7 min.
The multiwell plates were then placed into a Labsystem 
Multiskan Plus Spectrophotometer (Helsinki, Finland). 
The absorbance was measured at 405 nm, with 495 nm as 
the reference wavelength. The absorbance at 495 nm was 
deducted from the absorbance at 405 nm for all samples 
and controls. Then, the OD405−OD495 value of the back-
ground control, which is composed of the incubation buffer 
and ABTS solution, was subtracted from all OD405−OD495 
values of the samples. The intensity of apoptosis can be 
expressed as enrichment factor = (mU of the sample)/(mU 
of the corresponding negative control), where mU is the 
absorbance × 10−3 after subtracting the reference absorbance 
and the OD405−OD495 value of the background control. The 
enrichment factor exhibits the specific enrichment of mono-
nucleosomes and oligonucleosomes released into the cyto-
plasm of the cells that are dying and dead due to apoptosis. 
Finally, the values were normalized so that the untreated 
sample could have an enrichment factor equal to 1.32
Laser treatment
We used 2 W of power laser (Apel Laser, Bucharest, Romania) 
operating at 808 nm for a 2 minutes irradiation of a monolayer 
of cells placed on a glass substrate, after being incubated with 
HSA–MWCNTs for various periods of time. The laser diode 
was placed 3 cm away from the surface of the glass, at a   vertical 
angle, and the beam had a Gaussian distribution with a 1/e2 
value of 2 mm.
Laser confocal microscopy of cells
Fluorescent images were acquired using a Zeiss LSM 
710 confocal laser scanning unit (Oberkochen, Germany) 
equipped with argon and an HeNe laser mounted on an Axio 
Observer Z1 Inverted Microscope. Hep2G cells or human 
hepatocytes from the suspension were briefly rinsed with 
PBS and fixed in 4% formaldehyde (pH 7) for 15 min. After 
three washing procedures in PBS for 15 min, the slides were 
covered for 60 min with a serum-free blocking buffer (Dako 
Cytomation, Glostrup, Denmark). The dying procedures were 
made in accordance with manufacturers’ protocols. Specific 
visualization of cell structures was performed using 364, 
488, and 568 nm excitation laser lines to detect Draq5 (BP 
590–650 nm emission), DAPI (BP 385–470 nm emission), 
FITC (BP505–550 emission), and cy3 fluorescence (LP585 
emission), respectively.
Transmission electron  
microscopy analysis
The internalization of the functionalized nanotubes was 
investigated using transmission electron microscopy (TEM) 
in conventional electron beam conditions. Live cells were 
incubated in an HSA–MWCNT solution as described pre-
viously. After the final PBS rinsing, the cells were fixed 
using 2.5% glutaraldehyde in 0.1 M cacodylate buffer 
and embedded in agarose. After three rinses with sodium 
phosphate buffer, the monolayers were sectioned into small 
pieces, postfixed with 1% osmium tetroxide, en bloc stained 
with 1% uranyl acetate, dehydrated in graded ethanol series 
(30%, 50%, 75%, 100%, 10 min each), and embedded in 
EMbed 812 resin. Ultrathin (∼100 nm) sections were cut on 
an LEICA EM UC6 Ultramicrotome (Leica Microsystems, 
Wetzlar, Germany), poststained with 4% uranyl acetate and 
lead citrate, and viewed using a Jeol JEM 1010 TEM (Jeol, 
Tokyo, Japan). The images were captured using a Mega 
VIEW III camera (Olympus, Soft Imaging System, Münster, 
Germany).
statistical data analysis
All data were expressed as mean ± standard error of the mean. 
Nonparametric tests were selected due to data nonnormality 
(Kolmogorov–Smirnov test). Between-group comparisons 
for the same concentration were tested using the Wilcoxon 
test. Alpha error level of ,0.05 was selected for all tests. 
SPSS Statistics Version 17.0 (Chicago, IL, USA) packages, 
as well as the Microsoft Office Excel application, were used 
for data analysis.
Results
Functionalization of MWcNTs with hsA
In order to obtain a directly targeted delivery of MWCNTs 
into the cancer cells and to visualize and detect the localiza-
tion of the nanotubes inside the cell, the FITC–HSA system 
was preformed and noncovalently labeled on the oxidized 
surface of MWCNTs.
To provide clues regarding the success of noncova-
lent HSA–MWCNT functionalization, confocal micros-
copy was proposed for the identification of FITC-labeled 
CNTs in solution. As shown in Figure IC, globular green International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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CNTs corresponding to large molecules of fluorescent 
  albumin were observed.
The oxidation of the nanotubes using a 3:1 (v/v) mixture 
of concentrated sulfuric and nitric acid gave them hydrophi-
licity and stability in aqueous systems due to the formation 
of –COOH, OH groups at the end and along the sidewalls 
of the tubes.21
FTIR spectra from Figure 2A confirm successful oxidation. 
Comparing the FTIR spectra of pristine MWCNTs (black) with 
those of oxidized MWCNTs (red), the characteristic bands of 
the oxygen-containing groups appear at 3422 cm−1, correspond-
ing to the stretching vibration of O–H and water,33 a band at 
1721 cm−1, corresponding to the carbonyl and carboxyl C=O 
stretching vibration, at 1582 and 1380 cm−1, corresponding to 
the O–H deformation vibration, and the band at 1117 cm−1, 
corresponding to the C–O stretching vibration. The band at 
620 cm−1 corresponds to the CO out-of-plane deformation.34
Further, we conjugated the HSA–FITC system noncova-
lently on the surface of oxidized MWCNTs. First, we covalently 
labeled HSA with FITC at an increased pH (above pH = 9), as 
shown schematically in Figure IA.35 FITC covalently attached 
to the protein through the alpha-amino group. Second, HSA–
FITC complex was adsorbed on the nanotubes, presumptively, 
through electrostatic interactions between the functional groups 
of MWCNTs and the protein-positive domains (Figure IB). 
Considering the fact that not all the surface of the nanotubes is 
oxidized, hydrophobic interactions can also occur.36
UV–Vis spectroscopy is a simple but efficacious method 
that confirms the formation of the oxidized MWCNT–HSA–
FITC complex. The nanotubes solutions give an adsorption 
band at 295.7 cm−1, which corresponds to the +-plasmon 
transition of MWCNT.37
The yellowish HSA–FITC solution has the characteristic 
adsorption band at 489 cm−1 and a second adsorption band 
at 292 cm−1, suggesting the existence of aromatic amino 
acids from HSA. Comparing the aforementioned spectra, the 
formation of the MWCNTs–HSA–FITC complex becomes 
obvious due to the appearance of the oxidized MWNT band 
and the HSA–FITC band at 475.6 cm−1, which is shifted and 
has low intensity (Figure 2C).
Figure 1 A) Illustration of the covalent labeling of hsA with FITc. B) The formation of oxidized MWcNTs–hsA–FITc. C) A typical fluorescent image of HSA–MWCNTs 
(100 mg/L): globular fluorescent CNTs corresponding to attached large molecules of fluorescent albumin are being observed. D) 140 × 120 nm AFM topographic image of 
hsA (black arrows) conjugated with MWcNTs (white arrows). The red arrow indicates the presence of an unconjugated hsA molecule. The scale bar represents 20 nm 
(bottom-right panel).
Abbreviations: AFM, atomic force microscopy; FITC, fluorescein isothiocyanate; HSA, human serum albumin; MWCNTs, multiwalled carbon nanotubes.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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The conjugation of HSA–FITC onto the surface of the 
nanotubes is also confirmed by FTIR spectroscopy as seen in 
Figure 2B. No similarity can be observed when comparing the 
spectra of HSA–FITC with those of the nanotube-conjugated 
HSA–FITC. All the corresponding peaks had shifted their 
position, and some even disappeared. In the higher region, 
the stretching vibration band of the N–H groups at 3409 cm−1 
changed their shape in a broad band that included two peaks: 
one at 3389 cm−1 (N–H groups stretching vibration) and the 
second at 3303 cm−1, which is the pyridine aromatic C–H 
vibrations band. The aliphatic C–H stretching vibration at 
2929 and 2873 cm−1 moved at 2922 and 2865 cm−1, such 
that these groups were involved in electrostatic bonds. In 
addition, the amide I and II are shifted to low frequency: 
amide I, from 1656 to 1649 cm−1; amide II, from 1544 to 
1532 cm−1. The asymmetric and symmetric deformations 
of CH3 have changed their bands from 1459 to 1447 cm−1 
and 1416–1389 cm−1, respectively. The region in between 
has dramatically changed their intensity. This is due to the 
spontaneous adsorption of the crystalline HSA–FITC com-
plex on the MWCNTs and the formation of a well-organized 
oxidized MWCNT–HSA–FITC.
To that end, atomic force microscopy (AFM) analysis of the 
HSA–MWCNTs solution was performed. Representative AFM 
evidence of the successful attachment of HSA molecules onto 
the surface of the nanotubes is shown in Figure ID. By AFM, 
analysis at the nanometric scale of the two HSA molecules 
(black arrows in Figure ID) attached at the end of the nanotubes 
(white arrows) was carried out. A single HSA molecule (red 
arrow) has also been observed in the topographic image shown 
here. The length of the CNTs was estimated as being ,200 nm. 
The lateral resolution of an AFM image is determined by the 
tip of the object that is imaged. In the presented image, the 
width of the nanotube appears to be .2 nm, as we used an 
AFM tip with a ∼15 nm radius of curvature.
hsA–MWcNT internalization
The ability of an FITC-labeled bioconjugate of HSA–
MWCNTs to internalize inside an HepG2 cell was evaluated 
by confocal fluorescence microscopy imaging. The results 
presented in Figure 3B show that at low concentration and 
short exposure time, HSA–MWCNT accumulates inside 
HepG2 cells. Thus, we provided imaging evidence that 
HSA can act as a carrier for MWCNTs, and because we 
A
B
C
A
b
s
o
r
b
a
n
c
e
 
(
a
.
u
.
)
A
b
s
o
r
b
a
n
c
e
 
(
a
.
u
.
)
A
b
s
o
r
b
a
n
c
e
 
(
a
.
u
.
)
0
0.0
0.2
0.4
1
2
4000 3500 2500 2000 1500 1000 500
1.0
0.5
0.0
300 400 500 600
3000
4000 3500 2500 2000 1500 1000 500 3000
Wavenumber (1/cm)
Wavenumber (1/cm)
MWCNTs
Oxidized MWCNTs
Oxidized MWCNTs
Oxidized MWCNTs–HSA–FITC
3422 cm–1
3422 cm–1
3409 cm–1
3389 cm–1 3303 cm–1
2929 cm–1
3060 cm–1
2873 cm–1
1656 cm–1
1649 cm–1
1531 cm–1
1544 cm–1
532 cm–1
605 cm–1
1582 cm–1
1721 cm–1
1300 cm–1
1117 cm–1
620 cm–1 HSA–FITC
λ (nm)
HSA–FTIC
Oxidized CNTs–HSA–FTIC
Figure 2 FTIr spectra of A) pristine MWcNTs (black) and oxidized MWcNTs (red); B) hsA–FITc (black) and hsA–FITc-coated oxidized MWcNTs (red); C) UV–Vis 
adsorption spectra of hsA–FITc (black), oxidized MWcNTs (blue), oxidized MWcNTs–hsA–FITc (red).
Abbreviations: FITc, fluorescein isothiocyanate; FTIR, Fourier transform infrared; HSA, human serum albumin; MWCNTs, multiwalled carbon nanotubes.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
135
Nanophotothermolysis of liver cancer in an in vitro assay using albumin-conjugated carbon nanotubes
were unable to identify any fluorescence in the epithelial 
cells in similar conditions (Figure 3A) we reasoned that 
HSA–MWCNT bioconjugates exhibit specific affinity for 
liver cancer cells.
Furthermore, phase contrast microscopy was used to 
demonstrate the presence of CNTs inside HepG2 cells fol-
lowing HSA–MWCNT administration. As seen in Figure 3E 
(red arrows), intracellular aggregates of MWCNTs appear as 
dark, optically dense signals that associate with a refringent 
signal under phase contrast. Once more, we were unable to 
identify any aggregates inside the epithelial cells that have 
been similarly treated. (Figure 3D) Moreover, the cellular areas 
that appeared to contain MWCNTs were further subjected to 
TEM analysis. When these regions were observed under TEM, 
MWCNTs could be clearly identified in the form of intracel-
lular aggregates, as shown by the red arrows in Figure 3F.
The mechanism of selective  
internalization of hsA–MWcNTs  
inside the malignant liver cells
In order to shed light on the molecular mechanisms involved 
in the specific uptake of HSA–MWCNTs in HepG2 cells, 
we investigated the possibility that a 60 kDa glycoprotein, 
Gp60, which is known to function in albumin transcytosis 
in malignant cells,38 was involved in the selective uptake of 
albumin bound to CNTs. To accomplish this, we allowed the 
cells treated with 5 mg/L HSA–MWCNTs for 1 h to incor-
porate cy3–anti-Gp60 Ab for 30 min at 37°C. To that end, we 
obtained fluorescent images demonstrating the internalized 
cy3 fluorescence (Figure 4A, first panel).
Also, we showed that HepG2 cells internalized with 
albumin-bound MWCNTs (fluorescently labeled with FITC) 
were distributed into the punctate structure inside the cells 
(Figure 4A, 2nd panel). DAPI, which is known to form fluo-
rescent complexes with natural double-stranded DNA, was 
used for nuclei staining. In Figure 4A, fourth panel, nearly 
complete colocalization of the FITC fluorescence (green 
image) and cy3 fluorescence (red image) was evident by yel-
low in the merged image. This finding suggests that albumin 
bound to MWCNTs was incorporated into plasmalemmal 
vesicles containing Gp60 as a membrane protein, further 
validating HSA–MWCNT specificity for Gp60 receptors. 
Importantly, as seen in Figure 4B, no significant colocaliza-
tion in the hepatocyte cells (CRL-4020) was observed for 
ABC
DE F
10 µm 10 µm 10 µm
Figure 3 selective nanophotothermolysis of hepg2 cells. A) confocal image of human hepatocytes incubated for 30 min with 5 mg/L FITc–hsA–MWcNTs. (The nucleus 
was stained with DrAQ5-red.) B) confocal detection of MWcNT–hsA–FITc (green) selectively internalized into hepg2 cells (exposed for 30 min to 5 mg/L of FITc–hsA–
MWcNTs). C) hepg2 cells were irradiated for 2 min using a 2-W, 808-nm laser beam. Image of cell lysate and aggregated cells after internalization of MWcNT–hsA–FITc 
and laser radiation. D) crL-4020 cells incubated for 30 min with 5 mg/L FITc–hsA–MWcNTs visualized by phase contrast microscopy (×400 magnification). E) hepg2 cells 
incubated for 30 min with 5 mg/L FITc–hsA–MWcNTs visualized by phase contrast microscopy (×400 magnification). F) Transmission electron microphotograph showing 
clusters of MWCNTs surrounded by plasmalemmal vesicles, confirming the presence of nanomaterial inside the cell (×24,000 magnification).
Abbreviations: FITc, fluorescein isothiocyanate; HSA, human serum albumin; MWCNTs, multiwalled carbon nanotubes.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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cy3–Gp60 Ab and HSA–FITC–MWCNTs incubated under 
same circumstances.
Therefore, based on these data, we showed that HSA–
MWCNTs can act as specific and sensitive site-targeted 
nanosystems against Gp60 receptor located on the liver 
cancer cell membrane.
Association of caveolin-1 with  
FITc–hsA–MWcNTs-containing vesicles
Most data indicate that caveolae-mediated endocytosis in 
cells is stimulated by the binding of albumin to Gp60, a 
receptor located in the caveolae.38
Given these data and the described role of caveolin in 
albumin endocytosis, we reasoned that the mechanism of 
HSA–MWCNT internalization in HepG2 cells was similar. To 
test this hypothesis, we immunostained the HepG2 cells with 
Cy3–anti-caveolin-1 Ab. As shown in Figure 4C, confocal 
imaging revealed that the majority of FITC–HSA–MWCNT-
containing plasmalemmal vesicles stained for caveolin-1 
used this fluorescent anti-caveolin-1 monoclonal Ab. Taken 
together, all these data demonstrate that HSA–MWCNTs 
selectively internalize in human hepatocellular cancer cells 
via caveolae-mediated endocytosis by the binding of the albu-
min carrier to Gp60, a specific albumin-binding protein.
cytotoxicity induced by laser  
irradiation or by the administration  
of hsA–MWcNTs
Before testing the in vitro response of HSA–MWCNT-treated 
cells to laser irradiation, we investigated the possible effect 
of cytotoxicity induced by the administration of CNTs in 
the cells. HepG2 cells and the epithelial cells were treated 
with various concentrations of HSA–MWCNT at various 
incubation periods. Cell Death Detection ELISAPLUS was 
used to evaluate the effect of MWCNT bioconjugates on 
cell viability.
After 24 h of incubation, HepG2 exposed to 50 mg/L 
of HSA–MWCNT showed a 5.71% decrease in viability 
compared with 1.6% (P , 0.02) (Table I). For human hepa-
tocytes exposed to 50 mg/L of HSA–MWCNT, the decrease 
in viability was 6.23% compared with the nontreated sample,   
in which the percentage of viable cells was 98.7% (P , 0.001). 
A
B
C
Cy-Gp60 Ab
Cy-Gp60 Ab
Caveolin-1-Cy3 Ab
FITC–HSA–MWCNTs
FITC–HSA–MWCNTs
FITC–HSA–MWCNTs
DAPI
DAPI
DAPI
Merged HepG2
HepG2
CRL-4020 Merged
Merged
Figure 4 hsA–MWcNTs in vitro endocytosis mechanism in human liver cancer cells. A) colocalization of cy-gp60 antibody and FITc–hsA–MWcNTs in hepg2 cells. 
B) colocalization of cy-gp60 antibody and FITc–hsA–MWcNTs in hepatocyte epithelial cells. C) colocalization of caveolin-1-cy antibody and FITc–hsA–MWcNTs in 
hepg2 cells. results are representative of three experiments. scale bar: 20 µm in all panels.
Abbreviations: DAPI, 4′-6-diamidino-2-phenylindole; FITC, fluorescein isothiocyanate; HSA, human serum albumin; MWCNTs, multiwalled carbon nanotubes.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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The statistical data showed that nanomaterial exposure per se 
induced no significant cytotoxic effects at small and medium 
concentrations (P . 0.05 for all comparisons).
The next step in order to eliminate any potential errors 
was represented by a 2 minutes irradiation of a sample of cells 
without nanoparticles, using a 2 W, 808 nm laser beam. There 
was no lysis among the cells after irradiation. The process 
demonstrates the transparency of HepG2 for NIR beam.
Assessment of cellular necrosis  
after laser treatment and  
administration of hsA–MWcNTs
The postirradiation lysis rate of HepG2 cells treated with 
HSA–MWCNTs ranged from 35.45% (for 1 mg/L) to 88.24% 
(for 50 mg/L) at 60 sec (P , 0.001), whereas at 30 min the 
necrotic rate increased from 59.34% (1 mg/L) to 92.34% 
(50 mg/L), P value ,0.001. Significantly lower apoptotic 
rates were obtained in irradiated epithelial cells treated for 
60 sec and 30 min at concentrations ranging from 1 mg/L 
to 50 mg/L (6.78%–64.32% for 60 sec; 9.89%–70.78% for 
30 min). As can be observed, the optimal apoptotic effect of 
malignant cells after incubation with HSA–MWCNT was 
obtained at a concentration of 5 mg/L (HepG2/CRL-4020: 
65.79%/11.34% at 60 sec, and 75.34%/14.67% at 30 min) 
(Figure 5). After 60 min of incubation, the difference among 
the apoptotic rates was also statistically significant among 
the two cell lines for low/medium concentrations of HSA–
MWCNT (78.92%: 1 mg/L, 88.34%: 5 mg/L, 87.88%: 
20 mg/L, for HepG2; 15.56%: 1 mg/L, 21.34%: 5 mg/L, 
52.14%: 20 mg/L, for CRL-4020). P values were ,0.001 
for comparisons between various forms of nanomaterials. 
No significant differences (P = 0.143) among the apoptotic 
rates of HepG2 and CRL-4020 treated with HSA–MWCNT 
could be observed (100%: HepG2; 84.13%: CRL-4020) for 
a high concentration of nanomaterials (50 mg/L).
After 3–5 h of incubation, a significant apoptotic rate 
of the two cell lines was obtained only when the cells 
were treated with low concentrations of nanomaterials 
(,20 mg/L). Elevated concentrations recorded a nonsignifi-
cant difference in the cell lysis effect of the two cell lines 
(P = 0.256–20 mg/L; P = 0.296–50 mg/L).
After 24 h of incubation, the HepG2 cells treated with 
1 mg/L HSA–MWCNT were 100% necrotic after laser irra-
diation, as compared with 52.2% of the CRL-4020 cells simi-
larly treated. For very low concentrations of HSA–MWCNTs, 
we could observe a difference among the percentage of 
dead cells of the two cell lines. However, the difference 
reached only a marginal significance (P = 0.07). The lysis 
rate of the irradiated cells incubated with more than 5 mg/L 
  nanomaterials for 24 h was almost similar for the two cell 
lines (100% vs 85.94%).
In contrast, no significant differences in the percentage 
of nonviable cells were obtained between the two cell lines 
when the nonfunctionalized MWCNT solution was used for 
treatment (P . 0.05 for all comparison and each exposure 
interval). Moreover, for HepG2 cells, the results showed a 
significant difference between MWCNTs and MWCNT–
HSA-exposed groups for low concentrations (1, 5, and 
20 mg/L) and short exposures (60 sec, 30 min, 1 h, 3 h, and 
5 h) (Figure 5).
Discussion
The main goal of this investigation was to develop and test a 
new method of treatment of human HCC. Preliminary data 
from literature support the involvement of albumin in tumor 
growth. The implication is supported by the fact that albumin 
enhances tumor expansion, as it is used for synthesis in vari-
ous cellular compartments.38
In order to investigate the toxicity effects of the nano-
conjugates, HepG2 cells and CRL-4020 epithelial cells were 
exposed and incubated with HSA–MWCNTs at various 
concentrations and incubation times. Consistent with other 
findings, we demonstrate that only high concentrations of 
MWCNT bioconjugates exhibit cytotoxic effects.31 Never-
theless, the toxicity, which represents a major obstacle in 
using CNTs in clinical applications, may be minimized by 
administration of low doses of nanoconjugates.9,13,23
Further, we used HSA–MWCNTs as heat-inducing 
agents under laser radiation during the process of 
Table  1  cytotoxic-induced  effects  on  hepg2  and  crL-4020 
cells  by  various  concentrations  of  bionanomaterial  at  various 
incubation times
HSA–MWCNTs  
concentration
Cytotoxicity effects at different incubation 
intervals (%)
1 min 30 min 1 h 3 h 5 h 24 h
crL-4020 control 0 0.2 0.3 0.4 0.9 1.6
hepg2 control 0 0.1 0.3 0.5 1.1 1.3
crL-4020 1 mg/L 0.3 0.5 0.7 1.9 2.4 3.8
hepg2 1 mg/L 0.5 0.8 0.9 2.2 2.5 3.6
crL-4020 5 mg/L 0.6 0.9 1 2.4 3.1 4.2
hepg2 5 mg/L 0.4 0.7 0.8 2.6 3.2 4.4
crL-4020 20 mg/L 0.7 0.8 1.2 3 3.1 4.8
hepg2 20 mg/L 0.8 1.2 1.2 2.6 2.8 4.5
crL-4020 50 mg/L 0.6 0.8 1.8 2.2 2.8 4.9
hepg2 50 mg/L 1.4 1.5 1.6 2.2 2.8 6.2
Abbreviations:  hsA,  human  serum  albumin;  MWcNTs,  multiwalled  carbon 
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nanophotothermolysis. This method is based on the pres-
ence and clustering of HSA–MWCNTs inside the cells and 
their highly optical absorption capabilities responsible for 
inducing thermal effects, especially under NIR irradiation, 
where the biological systems have low absorption and high 
transparency.10,19–22,39,40 The optoelectronic transitions in 
the graphitic structures of the MWCNTs clusters generate 
thermal energy41 that rapidly diffuses into the subcellular 
compartments, where the nanoconjugates are present.
Laser-induced thermal ablation of cancer cells labeled 
with HSA–MWCNTs may be used in two main modes: 
pulsed and continuous. The pulsed mode produces localized 
(few micrometers) damage of individual cancer cells by 
laser-induced micro- and nanobubbles around overheated 
nanoparticles without harmful effects on the surrounding 
healthy cells.42 It particularly favors in vivo killing of single 
circulating tumor cells using just 1 ns laser pulses. The   second 
mode is more time consuming (a few minutes of exposure) and 
results in the effects of thermal denaturation and coagulation 
as main mechanisms of cell damage. It is more appropriate for 
the treatment of primary tumors measuring a few   millimeters 
or more.42
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The use of continuous laser irradiation proved sig-
nificant differences in HepG2 postirradiation apoptotic 
percentage (P , 0.05) for concentrations of ,20 mg/L, 
at 60 sec and 30 min, compared with the apoptotic rate 
of CRL-4020. This finding may be particularly relevant 
for low concentrations of HSA–MWCNTs (eg, plasma 
levels after intra-arterial administration).43 It has been 
previously stated that the mechanism of HepG2 uptake 
for albumin is a caveolae-dependent endocytosis similar 
to that for other types of ligands such as cholesterol or 
folic acid.44 The mechanism represents a distinct form of 
transport and elicits features different from independent 
or clathrin-mediated endocytosis. After internalization of 
caveolae, the biomaterials are accumulated in caveosomes, 
a specific type of organelles.45 Folic acid has been intensely 
studied for its potential in targeted therapies. Significant 
results were obtained after binding folate-functionalized 
poly (ethylene glycol)-coated nanoparticles to the targeted 
receptor (folate receptor).46 Within the field of chemo-
therapy, caveolae-mediated transport mechanisms have 
been largely used for targeted drug delivery. The pathway 
has been preferred as it was demonstrated to be a nondeg-
radative mechanism using pH-dependent chemotherapy 
release. For instance, a combination of cytostatic drugs 
and albumin called Trexall® (Duramed Pharmaceuticals, 
New York, NY, USA) is currently prescribed for the treat-
ment of metastatic liver cancer in humans.47 The literature 
has already suggested new ideas of targeted therapies that 
could elude lysosomal harmful transit and will therefore 
offer a higher protection level for drug compounds.48 A 
specific endothelin receptor associated with the described 
uptake mechanism is the Gp60 receptor (albondin).49 Using 
phase contrast, confocal, and TEM, we demonstrated in 
this study, without precedent, that the mechanism of HSA–
MWCNT uptake in HepG2 cells occurs through caveolae-
dependent endocytosis initiated by the albumin-binding 
Gp60 receptor (albondin) (Figure 4).
In the present study, we observed that in the treatment of 
HepG2 cells with high concentrations of HSA–MWCNTs 
for more than 5 h, the percentage of necrotic HepG2 cells 
is not significantly different from that of epithelial cells. 
This finding suggests a nonselective, passive intracellular 
diffusion of nanomaterial inside the cells when the cells are 
exposed to high concentrations of nanomaterials for long 
periods of time.
In contrast, we obtained a selective lysis of HepG2 cells 
treated with HSA–MWCNTs for incubation periods shorter 
than 30 min, regardless of the concentration. In cellular 
systems, the molecular membrane association/dissociation 
processes are very short, ranging from seconds to minutes.50 
Therefore, our finding could be of decisive importance when 
using HSA–MWCNTs for the in vivo targeting of liver 
cancer cells.
Conclusion
We have developed a method of functionalization of CNT 
with human albumin for the selective targeting of liver 
cancer cells. Moreover, to our knowledge, this is the first 
evidence of improved selective thermal ablation of liver 
cancer cells using HSA–MWCNTs compared with the 
normal epithelial cells. Based on the results presented 
here, we believe that HSA–MWCNTs selectively attach to 
albondin (aka Gp60) receptor located on HepG2 cell mem-
brane, followed by uptake through a caveolin-dependent 
endocytosis process.
These results may represent a first step in the process 
of complete in vivo elimination of liver cancer cells using 
nanolocalized thermal ablation by means of laser heating.
However, further research is required in order to fully 
understand the mechanisms of selective binding of HSA–
MWCNTs in malignant cells.
Nevertheless, further investigations are also required 
for the careful assessment of unexpected toxicities and 
biological interactions of HSA–MWCNTs inside the living 
organism.
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